Perrotti, DaniloAgarwal, AnupriyaLucas, ClaireNarla, GouthamNevanini, PaoloOdero, Maria D.Ruvolo, Peter P.Verrills, Nicole M.2021-03-242021-03-242019-07-17Perrotti, D., Agarwal, A., Lucas, C. M., Narla, G., Neviani, P., Odero, M. D., ... & Verrills, N. M. (2019). Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”. Science translational medicine, 11(501), eaau0416. https://doi.org/10.1126/scitranslmed.aau04161946-623410.1126/scitranslmed.aau0416http://hdl.handle.net/10034/624385This article is not available on ChesterRep.LB100 does not sensitize CML stem cells to tyrosine kinase inhibitor–induced apoptosis.enCC0 1.0 Universalhttps://creativecommons.org/licenses/by-nc-nd/4.0/PP2ALB100CMLLEUKAEMIAComment on PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemiaArticle1946-6242Science Translational Medicine